The COVID-19 pandemic has forced countries around the world to take unprecedented measures to contain it. In particular, its impact on mobility has been enormous, causing a sudden decrease in the number of trips and changes in the choice and use of modes of transport. Furthermore, the effects of this health crisis on the social and economic spheres have aggravated inequalities between population groups, with women being one of the most affected groups, which may accentuate the already known gender gap in mobility. Based on these premises, we carried out a strategic analysis of urban mobility from the perspective of sustainability and gender equity in the context of the pandemic, identifying a set of effective strategies to address the post-COVID-19 urban mobility scenario. To this end, based on the review of the literature and expert opinions, we carried out a Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis that allowed us to formulate 16 strategies after careful consideration of the weaknesses, strengths, threats and opportunities encountered. Our results provide useful recommendations for making successful policy decisions on post-COVID-19 mobility planning towards a more sustainable, equitable and safe model.
The role of gender and age in the risk of Road Traffic Injury (RTI) has not been fully explored and there are still significant gaps with regard to how environmental factors, such as road type, affect this relationship, including mobility as a measure of exposure. The aim of this research is to investigate the influence of the environmental factor road type taking into account different mobility patterns. For this purpose, a cross-sectional study was carried out combining two large databases on mobility and traffic accidents in Andalusia (Spain). The risk of RTI and their severity were estimated by gender and age, transport mode and road type, including travel time as a measure of exposure. Significant differences were found according to road type. The analysis of the rate ratio (Ratemen/Ratewomen), regardless of age, shows that men always have a higher risk of serious and fatal injuries in all modes of transport and road types. Analysis of victim rates by gender and age groups allows us to identify the most vulnerable groups. The results highlight the need to include not only gender and age but also road type as a significant environmental factor in RTI risk analysis for the development of effective mobility and road safety strategies.
Each year, 1.35 million people worldwide die due to Road Traffic Injuries (RTI), highlighting the need for further research. The risk of RTI is usually estimated as the number of casualties divided by the level of exposure in a population. Identifying the most appropriate exposure measures is one of the most important current challenges in this field. This paper presents an analysis of exposure measures used in empirical studies on road accidents. The results show a large variability in the exposure measures used, ranging from more general measures (such as population figures or vehicle fleet) to more specific measures related to mobility (such as number of trips, distances or travel time). A comparison of the risk patterns found shows that there is a partial consensus on the profiles with the highest risk of road traffic injuries. In conclusion, there is a need for the international standardization of criteria and data to be recorded, at least injury severity and measures of exposure to mobility, as the travel time disaggregated by socio-demographic variables and mode of transport. Such data would provide higher-quality results on risk profiles and facilitate the implementation of more effective, knowledge-based road safety policies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.